Lobe Sciences Ltd (LOBE.CX)
0.02
0.00 (0.00%)
CAD |
CNSX |
May 01, 13:38
Lobe Sciences Total Assets (Quarterly): 2.190M for Nov. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
November 30, 2023 | 2.190M |
February 28, 2023 | 1.172M |
November 30, 2022 | 1.499M |
August 31, 2022 | 1.748M |
May 31, 2022 | 3.322M |
February 28, 2022 | 5.208M |
August 31, 2021 | 12.10M |
May 31, 2021 | 28.83M |
February 28, 2021 | 14.13M |
November 30, 2020 | 12.91M |
August 31, 2020 | 12.97M |
May 31, 2020 | 6.361M |
February 29, 2020 | 6.428M |
November 30, 2019 | 6.760M |
August 31, 2019 | 6.721M |
May 31, 2019 | 7.171M |
March 31, 2019 | 0.0049M |
December 31, 2018 | 0.0074M |
September 30, 2018 | 0.0048M |
June 30, 2018 | 0.0106M |
March 31, 2018 | 0.019M |
December 31, 2017 | 0.0303M |
September 30, 2017 | 0.0434M |
Date | Value |
---|---|
June 30, 2017 | 0.0592M |
March 31, 2017 | 0.0755M |
December 31, 2016 | 0.0349M |
September 30, 2016 | 0.0523M |
June 30, 2016 | 0.0668M |
March 31, 2016 | 0.0819M |
December 31, 2015 | 0.0905M |
September 30, 2015 | 0.2088M |
June 30, 2015 | 0.2234M |
March 31, 2015 | 0.2373M |
December 31, 2014 | 0.2552M |
September 30, 2014 | 0.2728M |
June 30, 2014 | 0.3046M |
March 31, 2014 | 0.3373M |
December 31, 2013 | 0.361M |
September 30, 2013 | 0.3896M |
June 30, 2013 | 0.425M |
March 31, 2013 | 0.463M |
December 31, 2012 | 0.4875M |
September 30, 2012 | 0.4958M |
June 30, 2012 | 0.5431M |
March 31, 2012 | 0.1579M |
December 31, 2011 | 0.184M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.172M
Minimum
Feb 2023
28.83M
Maximum
May 2021
8.095M
Average
6.575M
Median
Total Assets (Quarterly) Benchmarks
Biocure Technology Inc | 3.496M |
Core One Labs Inc | 7.400M |
Nova Mentis Life Science Corp | 0.0539M |
Nanosphere Health Sciences Inc | 0.0258M |
Algernon Pharmaceuticals Inc | 6.674M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.871M |
Shareholders Equity (Quarterly) | -0.6811M |
Debt to Equity Ratio | -0.5227 |
Current Ratio | 0.0829 |
Net Debt Paydown Yield | -3.60% |